SCHEMBL4015555

SCHEMBL4015555

COc1ccc(/C=C/C(=O)NCCc2c(C)[nH]c3c(F)ccc(C)c23)cc1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.49
MAPT P10636 6/20 0.49
KMT2A Q03164 4/20 0.48
MEN1 O00255 3/20 0.48
ALDH1A1 P00352 3/20 0.48
LMNA P02545 2/20 0.48
CYP1A2 P05177 1/20 0.47
CYP2C19 P33261 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
RAB9A P51151 1/20 0.46
GAA P10253 1/20 0.45
HDAC3 O15379 2/20 0.44
HDAC6 Q9UBN7 2/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HPGD P15428 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4015557 1.00 POLB (0.49) POLBMAPTKMT2AMEN1ALDH1A1
SCHEMBL4013528 0.94 MAPT (0.51) POLBMAPTKMT2AMEN1ALDH1A1
SCHEMBL4017819 0.90 MEN1 (0.47) POLBMAPTKMT2AMEN1ALDH1A1
SCHEMBL4669271 0.90 KMT2A (0.47) POLBMAPTKMT2AMEN1ALDH1A1
SCHEMBL4754381 0.90 KMT2A (0.47) POLBMAPTKMT2AMEN1ALDH1A1
SCHEMBL4754393 0.90 MEN1 (0.46) POLBMAPTKMT2AMEN1ALDH1A1
SCHEMBL4669514 0.90 MEN1 (0.46) POLBMAPTKMT2AMEN1ALDH1A1
SCHEMBL4014345 0.89 MMP1 (0.48) KMT2AMEN1
SCHEMBL4017820 0.89 MAPT (0.50) POLBMAPTKMT2AMEN1ALDH1A1
SCHEMBL4017823 0.89 MAPT (0.50) POLBMAPTKMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2014287-A1 Use of cinnamic acid derivatives as modulators of an EP2 receptor Bayer Schering Pharma Aktiengesellschaft (DE) 2009-01-14 EP disclosed
EP-2014287-A1 Use of cinnamic acid derivatives as modulators of an EP2 receptor Bayer Schering Pharma Aktiengesellschaft (DE) 2009-01-14 EP disclosed